Welcome to InfiCure Bio
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.
Based on a panel of in vivo models for these conditions including a proprietary model for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.
Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.
InfiCure Bio was selected as 2016 Connect Company in Västerbotten at the annual meeting of Connect in Umeå. Five companies were nominated for the prize and the winner was chosen by the Board of Connect Sweden. InfiCure [...]